Skip to NavigationSkip to content

News

0
Blood cancer drug Jakafi fails to show sufficient efficacy in LANTUS Phase II and III trials
0
Ageing global population and innovations in the treatment pipeline will be key drivers of growth in next five years, says GBI Research
0
Collaboration will develop a platform and knowledge base to help speed up and improve gene interpretation
0
Five of the company’s 10-strong late-stage biosimilar pipeline now filed with regulators 

Features

Dr Edward Wright, virologist and senior lecturer in medical microbiology, University of Westminster, on the extent of the Zika crisis and the race...